期刊文献+

柔肝健脾通络法治疗糖尿病合并缺血性卒中的临床观察 被引量:1

Clinical Observation on Rougan Jianpitongluo Formula in Treating Diabetic Patients with Ischemic Stroke
下载PDF
导出
摘要 目的观察柔肝健脾通络法治疗糖尿病合并缺血性卒中的临床疗效。方法 198例患者按就诊先后顺序随机分为中药治疗组99例,脱落10例,对照组99例,脱落11例。中药治疗组常规治疗加服"柔肝健脾通络"中药汤剂,对照组以常规治疗为主,两组疗程均为28 d。结果两组病例治疗后总有效率比较差异无统计学意义;两组病例治疗前后NHISS评分、焦虑量表评分、抑郁量表评分、生理领域、心理领域及社会关系领域评分比较差异有统计学意义,且中药治疗组优于对照组,差异有统计学意义。结论柔肝健脾通络中药治疗糖尿病合并缺血性卒中在改善患者的生活质量及缓解患病后的焦虑抑郁确有疗效,可很好地改善患者的精神状态,提高生存质量。 Objective To observe the clinical efficacy on diabetic patients with ischemic stroke treated with Rougan Jianpitongluo Formula. Methods A total of 198 cases were randomized into treatment group( n = 99,10 cases dropped) and control group( n = 99,11 cases dropped). The treatment group applied Chinese medicine Rougan Jianpitongluo decoction wone dose a day. In the control group,conventional treatment was applied. The duration of treatment was 28 days in the both groups. Results The scores of NHISS were improved in both groups,but the group comparison indicated that the result in the treatment group was not better than that in the control group( P > 0. 05). The scores of HAMA SDS and WHOQOL- BREF were improved in both groups. The survival quality of patients was improved obviously and the difference was significant before and after treatment( P < 0. 05). The group comparison indicated that the result in the treatment group was better than that in the control group( P < 0. 05). The total effective rate in the treatment group was higher than that in the control group. Conclusion Rougan Jianpitongluo Formula achieves the definite efficacy on diabetic patients with ischemic stroke. It relieves greatly the clinical symptoms and physical signs and improves the survival quality of patients.
出处 《世界中西医结合杂志》 2015年第10期1394-1397,1401,共5页 World Journal of Integrated Traditional and Western Medicine
基金 北京市中医药科技项目(JJ2012-39)
关键词 糖尿病 缺血性卒中 柔肝健脾通络 Diabetic patients with ischemic stroke Rougan Jianpitongluo Clinical observation
  • 相关文献

参考文献5

二级参考文献25

  • 1胡维铭 王维治.神经内科主治医师699问[M].北京:北京医科大学、中国协和医科大学联合出版社,1998.410-410. 被引量:25
  • 2[3]HarlandJO, Unwin N, Bhopal RS, et al. Low levels of cardiovascular risk factors and coronary heart disease in a UKChinese population[J] .Epidemiol Community Health, 1997,51:642 被引量:1
  • 3[5]UK Prospective Diabetes Study Group. Tight blood pressurecontrol and risk of macrovascular and microvascular complications in type 2 diabetes[J ]. UKPDS 38.BM J, 1998, 17:703 被引量:1
  • 4[8]Chan JCN, Cockram CS. Diabetes in the Chinese populationand its implications for health care[J] . Diabetes Care, 1997,20: 1785 被引量:1
  • 5陈家伟.糖尿病与动脉粥样硬化[J].第三届分子糖尿病学研讨会论文编,2001,(17). 被引量:1
  • 6余叶蓉.胰岛素抵抗与糖尿病大血管病变[J].第三届分子糖尿病学研讨会论文编,2001,:13. 被引量:1
  • 7[23]UK prospective diabetes study(UKPDS) group. Intensivebloodglucose control with sulphonylureas or insulin comparedwith conventional treatment and risk of complications in patients with type 2diabetes (UKPDS 33) [J] .Lancet, 1998,352: 837 被引量:1
  • 8刘海英,王雅茹,朱爱辛.高血糖症引起红细胞平均体积假性增高[J].临床检验杂志,1998,16(5):302-304. 被引量:10
  • 9杨晔,贾红云,贾淑云.糖尿病并发脑梗塞的CT表现与临床分析[J].中风与神经疾病杂志,1999,16(1):55-55. 被引量:13
  • 10史洪润,杨玉庆,孟昭水,徐玉华,张文全.高血糖时红细胞聚集与急性脑梗塞关系的研究[J].中风与神经疾病杂志,1999,16(3):159-160. 被引量:79

共引文献11

同被引文献17

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部